Immix Biopharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLEICHROEDER LP | 11/14/2025 | 850.00 K | $1.78 M | 0.00% | 2.83% |
| VANGUARD GROUP INC | 11/07/2025 | 730.16 K | $1.53 M | 4.53% | 2.44% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 187.48 K | $391.87 K | 16.36% | 0.63% |
| MORGAN STANLEY | 11/14/2025 | 120.67 K | $252.20 K | -3.40% | 0.40% |
| STATE STREET CORP | 11/14/2025 | 98.96 K | $206.83 K | 130.35% | 0.33% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 90.86 K | $189.89 K | 78.76% | 0.30% |
| CITADEL ADVISORS LLC | 11/14/2025 | 89.80 K | $187.68 K | 100.00% | 0.30% |
| NORTHERN TRUST CORP | 11/14/2025 | 89.30 K | $186.64 K | -4.89% | 0.30% |
| UNITED CAPITAL FINANCIAL ADVISERS, LLC | 11/14/2025 | 70.68 K | $147.73 K | 100.00% | 0.24% |
| IMPRINT WEALTH LLC | 11/14/2025 | 67.42 K | $140.91 K | 100.00% | 0.22% |
| MARSHALL WACE, LLP | 11/13/2025 | 55.04 K | $115.02 K | 100.00% | 0.18% |
| BLACKROCK, INC. | 11/12/2025 | 43.07 K | $90.01 K | 6.87% | 0.14% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 11/13/2025 | 40.25 K | $84.12 K | 37.37% | 0.13% |
| XTX TOPCO LTD | 11/14/2025 | 35.15 K | $73.47 K | 100.00% | 0.12% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 35.00 K | $73.15 K | 40.00% | 0.12% |
| PRIVATE ADVISOR GROUP, LLC | 11/13/2025 | 31.23 K | $65.26 K | 0.00% | 0.10% |
| TRITONPOINT WEALTH, LLC | 10/15/2025 | 24.53 K | $51.26 K | 0.00% | 0.08% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 21.50 K | $44.94 K | 100.00% | 0.07% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 17.50 K | $36.58 K | 0.00% | 0.06% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/22/2025 | 16.04 K | $34.00 K | 0.00% | 0.05% |
| JANE STREET GROUP, LLC | 11/14/2025 | 14.97 K | $31.29 K | 100.00% | 0.05% |
| COLONY GROUP, LLC | 11/14/2025 | 11.90 K | $24.87 K | 0.00% | 0.04% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/24/2025 | 10.00 K | $20.90 K | 100.00% | 0.03% |
| 11/12/2025 | 10.00 K | $20.90 K | 100.00% | 0.03% | |
| SNOWDEN CAPITAL ADVISORS LLC | 11/14/2025 | 10.00 K | $20.90 K | 100.00% | 0.03% |
| MAI CAPITAL MANAGEMENT | 11/10/2025 | 2.00 K | $4.18 K | 100.00% | 0.01% |
| UBS GROUP AG | 11/13/2025 | 1.94 K | $4.06 K | -86.12% | 0.01% |
| WELLS FARGO & COMPANY/MN | 11/13/2025 | 330 | $690 | 0.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 11/14/2025 | 80 | $167 | 0.00% | 0.00% |
| CITIGROUP INC | 11/10/2025 | 35 | $73 | 100.00% | 0.00% |
| SRS CAPITAL ADVISORS, INC. | 11/14/2025 | 34 | $71 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 12 | $25 | -91.37% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Immix Biopharma, Inc. institutional Ownership - FAQ's
During the previous two years, 39 institutional investors and hedge funds held shares of Immix Biopharma, Inc.. The most heavily invested institutionals were:
Bleichroeder LP: 850,000
VANGUARD GROUP INC: 730,162
GEODE CAPITAL MANAGEMENT, LLC: 187,476
MORGAN STANLEY: 120,670
STATE STREET CORP: 98,960
SUSQUEHANNA INTERNATIONAL GROUP, LLP: 90,858
9.26% of Immix Biopharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.20 M shares in the last 24 months. This purchase volume represents approximately $15.47 M in transactions.